Wednesday, February 10, 2010, 9:49pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Vision-Sciences Inc. (VSCI)

At 4:04AM SGT: 1.15 USD   0.00 (0.00%)  
 MORE ON VSCI 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Vision-Sciences, Inc. (NCM:VSCI) Delayed quote dataEdit
Last Trade:1.15 USD
Trade Time:4:04AM SGT
Change: 0.00 (0.00%)
Prev Close:1.15
Open:N/A
Bid:1.06 x 600
Ask:1.61 x 400
1y Target Est:5.00
Day's Range:N/A - N/A
52wk Range:0.75 - 2.17
Volume:0
Avg Vol (3m):16,776.2
Market Cap:42.38M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add VSCI to Portfolio   Download Data

 HEADLINES 
•Vision-Sciences, Inc. Schedules Fiscal Q3 2010 Conference Call for February 12, 2010
GlobeNewswire (Wed 3:56am)
•VISION SCIENCES INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 3)
•Vision-Sciences, Inc. Regains Compliance With Nasdaq Listing Rules
GlobeNewswire (Thu, Dec 3)
•VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Nov 25)
•VISION SCIENCES INC /DE/ Financials
EDGAR Online Financials (Wed, Nov 18)
•VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Fri, Nov 13)
•Vision-Sciences, Inc. Announces $6.2 Million in Revenue for the First Half of Fiscal 2010
GlobeNewswire (Fri, Nov 13)
•VISION SCIENCES INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
EDGAR Online (Fri, Nov 13)
•Vision-Sciences, Inc. Does Not Satisfy Nasdaq's Requirement to Maintain a Majority of Independent Directors
GlobeNewswire (Fri, Nov 13)
•Q2 2010 Vision-Sciences, Inc. Earnings Release - After Market Close
CCBN (Thu, Nov 12)
More Headlines for VSCI...
 ANALYST 
EPS Est (next year) (Mar-10) :N/A
EPS Est (in 2 years) (Mar-11) :N/A
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Vision-Sciences, Inc. engages in the design, development, manufacture, and marketing of endoscopy products. The company operates through two segments, Medical and Industrial.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices